-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RV1oeySVVWNSuZAaAFCaSASJrLvLovfHb5KysxnWeZrHmSF59JdrLOOOZC/QKkb5 WN1Nchii+Onv+bizMnuyDQ== 0000909012-09-000418.txt : 20090218 0000909012-09-000418.hdr.sgml : 20090218 20090218161250 ACCESSION NUMBER: 0000909012-09-000418 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081231 FILED AS OF DATE: 20090218 DATE AS OF CHANGE: 20090218 EFFECTIVENESS DATE: 20090218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PERCEPTIVE ADVISORS LLC CENTRAL INDEX KEY: 0001224962 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-10438 FILM NUMBER: 09618804 BUSINESS ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-205-5340 MAIL ADDRESS: STREET 1: 499 PARK AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR/A 1 t305099.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F-HR/A Form 13F COVER PAGE Report for the Calendar Year of Quarter Ended: December 31, 2008 Check here if Amendment [X]; Amendment Number: 1 This Amendment (Check only one.): [ ] is a restatement. [X] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Perceptive Advisors LLC Address: 850 Third Avenue, 21st Floor New York, NY 10022 Form 13F File Number: 28-10438 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Joseph Edelman Title: Managing Member Phone: (646) 205-5342 Signature, Place, and Date of Signing: /s/ Joseph Edelman New York, NY February 18, 2009 - ------------------ ------------ ----------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ----------- Form 13F Information Table Entry Total: 88 ----------- Form 13F Information Table Value Total: $331,208 ----------- (thousands) List of Other Included Managers: {None}
Market Shares Value or PRN SH/ Put/ Investment Other Voting Authority Name of Issuer Title of Class CUSIP (*1000) Amount PRN Call Discretion Managers Sole Shared None AMAG PHARMACEUTICALS INC COM 00163U106 7,170 200,000 C SOLE 200,000 AMAG PHARMACEUTICALS INC COM 00163U106 8,604 240,000 P SOLE 240,000 AMAG PHARMACEUTICALS INC COM 00163U106 717 20,000 SH SOLE 20,000 ATS MED INC NOTE 6.000%10/1 002083AB9 897 1,250,000 PRN SOLE 1,250,000 ABBOTT LABS COM 2824100 534 10,000 SH SOLE 10,000 ACCURAY INC COM 4397105 52 10,000 SH SOLE 10,000 AETNA INC NEW COM 00817Y108 3,471 121,800 SH SOLE 121,800 AFFYMETRIX INC NOTE 3.500% 1/1 00826TAG3 1,170 3,900,000 PRN SOLE 3,900,000 ALEXION PHARMACEUTICALS INC COM 15351109 6,811 188,190 SH SOLE 188,190 ALLOS THERAPEUTICS INC COM 19777101 1,040 170,000 SH SOLE 170,000 AMGEN INC COM 31162100 5,775 100,000 C SOLE 100,000 AMICUS THERAPEUTICS INC COM 03152W109 14 1,800 SH SOLE 1,800 AMYLIN PHARMACEUTICALS INC COM 32346108 2,170 200,000 C SOLE 200,000 AMYLIN PHARMACEUTICALS INC COM 32346108 217 20,000 P SOLE 20,000 ANTIGENICS INC DEL COM 37032109 108 225,600 SH SOLE 225,600 ARQULE INC COM 04269E107 42 10,038 SH SOLE 10,038 BIOCRYST PHARMACEUTICALS COM 09058V103 79 57,600 SH SOLE 57,600 BIOGEN IDEC INC COM 09062X103 9,526 200,000 C SOLE 200,000 CARDINAL HEALTH INC COM 14149Y108 689 20,000 SH SOLE 20,000 CELL GENESYS INC COM 150921104 0 72 SH SOLE 72 CELERA CORP COM 15100E106 445 40,000 SH SOLE 40,000 CELGENE CORP COM 151020104 27,640 500,000 C SOLE 500,000 CELGENE CORP COM 151020104 5,528 100,000 P SOLE 100,000 CELGENE CORP COM 151020104 553 10,000 SH SOLE 10,000 CYCLACEL PHARMACEUTICALS INC COM 23254L108 235 558,397 SH SOLE 558,397 CYPRESS BIOSCIENCES INC COM PAR $.02 232674507 3,603 526,800 C SOLE 526,800 CYPRESS BIOSCIENCES INC COM PAR $.02 232674507 14,569 2,130,000 P SOLE 2,130,000 CYPRESS BIOSCIENCES INC COM PAR $.02 232674507 64 9,400 SH SOLE 9,400 CYTOKINETICS INC COM 23282W100 55 19,200 SH SOLE 19,200 DENDREON CORP COM 24823Q107 12,824 2,800,000 C SOLE 2,800,000 DENDREON CORP COM 24823Q107 2,252 491,700 P SOLE 491,700 DYAX CORP COM 26746E103 2,750 755,536 SH SOLE 755,536 ELAN PLC ADR 284131208 82 13,700 SH SOLE 13,700 ENZON PHARMACEUTICALS INC COM 293904108 280 48,000 SH SOLE 48,000 EXELIXIS INC COM 30161Q104 2,782 554,064 SH SOLE 554,064 EXPRESS SCRIPTS INC COM 302182100 2,409 43,807 SH SOLE 43,807 FOREST LABS INC COM 345838106 1,274 50,000 P SOLE 50,000 FOREST LABS INC COM 345838106 548 21,500 SH SOLE 21,500 GENENTECH INC COM NEW 368710406 11,931 143,900 P SOLE 143,900 GENENTECH INC COM NEW 368710406 9,550 115,185 SH SOLE 115,185 GENZYME CORP COM 372917104 3,486 52,519 SH SOLE 52,519 GILEAD SCIENCES INC COM 375558103 2,577 50,400 SH SOLE 50,400 HANSEN MEDICAL INC COM 411307101 320 44,357 SH SOLE 44,357 HI-TECH PHARMACAL INC COM 42840B101 562 101,488 SH SOLE 101,488 HUMAN GENOME SCIENCES INC NOTE 2.250% 8/1 444903AM0 679 2,300,000 PRN SOLE 2,300,000 INDEVUS PHARMACEUTICALS INC NOTE 6.250% 7/1 454072AC3 77,364 40,505,000 PRN SOLE 40,505,000 INDEVUS PHARMACEUTICALS INC COM 454072109 5,230 1,665,588 SH SOLE 1,665,588 INTERMUNE INC COM 45884X103 1,058 100,000 C SOLE 100,000 INTERMUNE INC COM 45884X103 529 50,000 P SOLE 50,000 INVERNESS MED INNOVATIONS IN COM 46126P106 11,779 622,913 SH SOLE 622,913 ISIS PHARMACEUTICALS INC COM 464330109 2,836 200,000 C SOLE 200,000 MANNKIND CORP COM 56400P201 103 30,000 SH SOLE 30,000 MEDIVATION INC COM 58501N101 557 38,200 C SOLE 38,200 MEDIVATION INC COM 58501N101 20,060 705,491 SH SOLE 705,491 MOMENTA PHARMACEUTICALS INC COM 60877T100 2,900 250,000 C SOLE 250,000 MOMENTA PHARMACEUTICALS INC COM 60877T100 348 30,000 P SOLE 30,000 MOMENTA PHARMACEUTICALS INC COM 60877T100 118 10,200 SH SOLE 10,200 NILE THERAPEUTICS INC COM 654145101 1 960 SH SOLE 960 NORTHFIELD LABS INC COM 666135108 198 200,000 SH SOLE 200,000 NORTHSTAR NEUROSCIENCE INC COM 66704V101 61 50,000 SH SOLE 50,000 NOVACEA INC COM 66987B103 427 284,475 SH SOLE 284,475 ONYX PHARMACEUTICALS INC COM 683399109 71 2,070 SH SOLE 2,070 OPTIMER PHARMACEUTICALS INC COM 68401H104 1,526 126,000 SH SOLE 126,000 OSCIENT PHARMACEUTICALS CORP COM NEW 68812R303 47 262,731 SH SOLE 262,731 PENWEST PHARMACEUTICALS CO COM 709754105 7,190 4,579,846 SH SOLE 4,579,846 PHARMATHENE INC COM 71714G102 233 101,212 SH SOLE 101,212 PHARMASSET INC COM 71715N106 498 38,000 SH SOLE 38,000 REPROS THERAPEUTICS INC COM 76028H100 495 47,071 SH SOLE 47,071 RIGEL PHARMACEUTICALS INC COM NEW 766559603 12 1,500 SH SOLE 1,500 SPDR TR UNIT SER 1 78462F103 6,317 70,000 P SOLE 70,000 SAVIENT PHARMACEUTICALS INC COM 80517Q100 1,656 286,010 SH SOLE 286,010 SEQUENOM INC COM NEW 817337405 198 10,000 C SOLE 10,000 SEQUENOM INC COM NEW 817337405 397 10,000 SH SOLE 10,000 SHIRE PLC SPONSORED ADR 82481R106 2,329 52,000 SH SOLE 52,000 STEMCELLS INC COM 85857R105 131 96,000 SH SOLE 96,000 TEVA PHARMACEUTICAL INDS LTD ADR 881624209 2,477 58,184 SH SOLE 58,184 3SBIO INC SPONSORED ADR 88575Y105 6,255 801,984 SH SOLE 801,984 TRANS1 INC COM 89385X105 9 1,251 SH SOLE 1,251 TRINITY BIOTECH PLC SPON ADR NEW 896438306 243 148,800 SH SOLE 148,800 UNITED THERAPEUTICS CORP DEL COM 91307C102 5,160 82,500 C SOLE 82,500 UNITED THERAPEUTICS CORP DEL COM 91307C102 8,090 129,318 SH SOLE 129,318 VARIAN MED SYS INC COM 92220P105 4,079 116,400 SH SOLE 116,400 VIROPHARMA INC COM 928241108 527 40,451 SH SOLE 40,451 WASHINGTON FED INC COM 938824109 317 21,200 P SOLE 21,200 WATSON PHARMACEUTICALS INC COM 942683103 1,770 66,624 SH SOLE 66,624 WELLPOINT INC COM 94973V107 1,222 29,000 SH SOLE 29,000 YM BIOSCIENCES INC COM 984238105 6 14,880 SH SOLE 14,880 ZYMOGENETICS INC COM 98985T109 300 100,000 C SOLE 100,000
-----END PRIVACY-ENHANCED MESSAGE-----